As tensions might drag over the next decade, investors have to learn to operate under prolonged uncertainty, said Warburg Pincus' Charles Kaye.World Economyread more
Billionaire investor Howard Marks, the co-chairman of Oaktree Capital, predicts there won't be a recession in the U.S. for another two years.US Economyread more
Network officials also said voters should expect more of a Koch focus on grassroots activism throughout the 2020 election cycle.Politicsread more
One person was killed and five others wounded on Thursday in a shooting on the streets of Washington, D.C., not far from the White House, police said.U.S. Newsread more
Stores are extending hours and cities are spending on light shows as China tries to encourage consumers to spend more money at night.China Economyread more
New research suggests fewer girls pursue careers in STEM — science, technology, engineering and math — because they're better than boys at reading.Closing The Gapread more
Stocks in Asia Pacific edged up in Friday afternoon trade as a series of developments overnight on the U.S.-China trade front dampened hopes of a deal being reached between...Asia Marketsread more
GM's usage of temporary workers, potential closure of plants and health care contributions remain major sticking points, according to people familiar with the talks.Autosread more
In a room full of avowed capitalists, policies that sound to some like socialism are bound not to go over well.Delivering Alpharead more
Trump has criticized Facebook numerous times since becoming president, most recently posting on Twitter that the company's proposed digital currency, libra, will "have little...Technologyread more
Republicans and Democrats have long since separated themselves by ideology, leaving each more uniformly conservative or liberal than ever. And now a new data analysis by the...Politicsread more
(For a live blog on the U.S. stock market, click or type LIVE/ in a news window.)
* AT&T rises after activist Elliott urges asset sales
* Technology, healthcare indexes fall
* Dow up 0.1%, S&P 500 down 0.01%, Nasdaq off 0.2% (Updates to close)
NEW YORK, Sept 9 (Reuters) - U.S. stocks ended flat on Monday as increased expectations of stimulus from central banks around the world were offset by losses in technology and healthcare shares.
Investors also appeared to pull back from buying after the market posted solid increases last week, strategists said. Microsoft Corp was the day's biggest drag on the S&P 500 and Nasdaq.
The S&P 500 financial index was among the day's best-performing groups, rising 1.5%, with banks gaining 3.2% and U.S. Treasury yields up on rising bets of an interest rate cut at the U.S. Federal Reserve's September meeting.
Cementing those expectations, Fed Chairman Jerome Powell said late last week the central bank would "act as appropriate" to sustain economic expansion, a phrase that financial markets have read as a sign of an impending rate cut.
"This is kind of the eye of the storm," as investors await more news on interest rates or trade, said Paul Nolte, portfolio manager at Kingsview Asset Management in Chicago.
But, he said, "for the market to move significantly higher from here, we'd really need to see something happen on trade."
Stocks rose last week largely on easing worries about U.S.-China trade negotiations.
This week, the European Central Bank is expected to introduce new stimulus measures at its meeting on Thursday.
"The market is absorbing those gains from last week, and ... is in a wait-and-see regarding the European Central Bank meeting," said Quincy Krosby, chief market strategist at Prudential Financial in Newark, New Jersey. The Dow Jones Industrial Average rose 38.05 points, or 0.14%, to 26,835.51, the S&P 500 lost 0.28 point, or 0.01%, to 2,978.43 and the Nasdaq Composite dropped 15.64 points, or 0.19%, to 8,087.44.
Earlier on Monday, U.S. Treasury Secretary Steven Mnuchin said he did not see the threat of a recession as the Trump administration seeks to revive trade negotiations with China, adding he expected a positive year ahead for the U.S. economy.
In healthcare, Amgen fell 2.6% after analysts raised questions about data on the company's lung cancer drug, while the S&P 500 healthcare index was down 0.9%. The S&P 500 technology index ended down 0.7%.
Among gainers, energy stocks rose along with oil prices.
Among other stocks, AT&T Inc gained 1.5% after shareholder Elliott Management Corp disclosed a $3.2 billion stake in the company and pushed for changes.
Boeing Co fell 1.2% after it suspended load testing of its new widebody 777X aircraft over the weekend as media reports said a cargo door failed in a ground stress test.
Advancing issues outnumbered declining ones on the NYSE by a 1.49-to-1 ratio; on Nasdaq, a 1.51-to-1 ratio favored advancers.
The S&P 500 posted 38 new 52-week highs and three new lows; the Nasdaq Composite recorded 63 new highs and 59 new lows.
Volume on U.S. exchanges was 7.42 billion shares, compared with the 6.77 billion-share average for the full session over the last 20 trading days. (Reporting by Caroline Valetkevitch in New York Additional reporting by Uday Sampath in Bengaluru; Editing by Matthew Lewis and Jonathan Oatis)